Helix Acquisition Corp. II Files 8-K on Director/Officer Changes
Ticker: BBOT · Form: 8-K · Filed: Feb 10, 2025 · CIK: 1869105
| Field | Detail |
|---|---|
| Company | Helix Acquisition Corp. II (BBOT) |
| Form Type | 8-K |
| Filed Date | Feb 10, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, personnel-changes, filing
TL;DR
Helix Acquisition Corp. II 8-K: Director/officer changes and financial updates filed Feb 10, 2025.
AI Summary
Helix Acquisition Corp. II filed an 8-K on February 10, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The filing also includes financial statements and exhibits. The company is incorporated in the Cayman Islands and its principal executive offices are located at Cormorant Asset Management, LP in Boston, MA.
Why It Matters
This filing indicates potential shifts in the leadership and governance of Helix Acquisition Corp. II, which could impact its strategic direction and operations.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing changes in personnel and financial statements, with no immediate indication of significant financial distress or major strategic shifts.
Key Players & Entities
- Helix Acquisition Corp. II (company) — Registrant
- Cormorant Asset Management, LP (company) — Principal Executive Offices
- February 8, 2025 (date) — Earliest event reported
- February 10, 2025 (date) — Date of Report
FAQ
What specific changes were made regarding directors and officers?
The filing indicates the departure of directors, election of directors, and appointment of certain officers, along with details on compensatory arrangements for these officers.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on February 8, 2025.
Where are the principal executive offices of Helix Acquisition Corp. II located?
The principal executive offices are located at C/O Cormorant Asset Management, LP, 200 Clarendon Street, 52nd Floor, Boston, MA 02116.
What is the Commission File Number for Helix Acquisition Corp. II?
The Commission File Number is 001-41955.
What type of report is this filing?
This filing is a Current Report on Form 8-K.
Filing Stats: 1,046 words · 4 min read · ~3 pages · Grade level 10.4 · Accepted 2025-02-10 06:05:16
Key Financial Figures
- $0.0001 — red Class A ordinary share, par value $0.0001 per share HLXB The Nasdaq Stock Mar
Filing Documents
- ea0230467-8k_helixacq2.htm (8-K) — 32KB
- ea023046701ex10-1_helixacq2.htm (EX-10.1) — 39KB
- ea023046701ex10-2_helixacq2.htm (EX-10.2) — 5KB
- 0001213900-25-011454.txt ( ) — 262KB
- hlxb-20250208.xsd (EX-101.SCH) — 3KB
- hlxb-20250208_lab.xml (EX-101.LAB) — 33KB
- hlxb-20250208_pre.xml (EX-101.PRE) — 22KB
- ea0230467-8k_helixacq2_htm.xml (XML) — 4KB
02. Departure of Directors or Certain Officers
Item 5.02. Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers. On February 8, 2025, the board of directors (the "Board") of Helix Acquisition Corp. II (the "Company"), , appointed Mr. Albert A. Holman, III to the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board. Mr. Holman was appointed to serve as a Class III director with a term expiring at the Company's third annual meeting of shareholders. The Board has determined that Mr. Holman meets the applicable standards for an independent director under both the Nasdaq Stock Market Rules and Rule 10A-3 under the Securities Exchange Act of 1934. Mr. Holman will serve on the Audit Committee. Mr. Holman is the Founder and Co-Managing Partner of Chestnut Partners, Inc., a boutique investment bank that provides advice to public and private clients in the life science industry. Mr. Holman sits on the board of directors of Ratio Therapeutics Inc., a private radiopharmaceuticals company, chairs its Audit Committee and Compliance Committee, and is a member of its Compensation and Talent Committee. Mr. Holman has extensive investment banking experience, providing financial advice relating to private debt and equity capital formation, mergers and acquisitions, initial public offerings, valuations and joint ventures. Prior to founding Chestnut Partners, Inc. in 1995, Mr. Holman was Managing Director and Head of Kidder, Peabody & Co.'s New England Investment Banking Department, responsible for all public and private company coverage in New England. Before moving to Boston in 1993, he was based in New York since 1980 and served as the Head of several groups including Kidder's Life Science Group. Mr. Holman is a graduate of Harvard University's Graduate School of Business Administration and, he holds a B.A. from University of Michigan. He is a Trustee of Mass General Brigham Incorporated and the
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 10.1 Letter Agreement, dated February 8, 2025, by and between the Company and Albert A. Holman, III. 10.2 Joinder Agreement, dated February 8, 2025, by and between the Company and Albert A. Holman, III. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HELIX ACQUISITION CORP. II Date: February 10, 2025 By: /s/ Bihua Chen Name: Bihua Chen Title: Chief Executive Officer 3